Información de Agape ATP Corp, dividendo de Agape ATP Corp, actividades de los accionistas y más

Más Datos de Agape ATP Corp Compañía

Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The Company offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual.

Información de Agape ATP Corp



Símbolo de cotizaciónATPC

Nombre de la empresaAgape ATP Corp

Fecha de salida a bolsaSep 17, 2018

Director ejecutivoHow (Kok Choong)

Número de empleados16

Tipo de seguridadOrdinary Share

Fin del año fiscalSep 17

Dirección1705-1708 Level 17, Tower 2, Faber Tower

CiudadKUALA LUMPUR

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísMalaysia

Código postal58100

Teléfono60327325716

Sitio Webhttps://www.agapeatpgroup.com/index_php

Símbolo de cotizaciónATPC

Fecha de salida a bolsaSep 17, 2018

Director ejecutivoHow (Kok Choong)

Ejecutivos de Agape ATP Corp



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Kok Choong How

Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Company Secretary

--

Mr. Kam Fan (Andrew) Lee

Chief Financial Officer

--

Mr. Tjong Budisantoso, Ph.D.

Executive Director

--

Dr. Wilfrendo Fernando Cortizo, Ph.D.

Director

--

Dr. Ni Luh Dharmakert Natih

Independent Director

--

Ms. Rose Marie Kadende Marie Kadende Kaiser

Independent Director

--

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Kok Choong How

Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Company Secretary

--

Mr. Kam Fan (Andrew) Lee

Chief Financial Officer

--

Mr. Tjong Budisantoso, Ph.D.

Executive Director

--

Dr. Wilfrendo Fernando Cortizo, Ph.D.

Director

--

Dr. Ni Luh Dharmakert Natih

Independent Director

--

Ms. Rose Marie Kadende Marie Kadende Kaiser

Independent Director

--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

Por negocioUSD

Nombre

Ganancia

Proporción

Others – Products for the provision of complementary health therapies

222.64K

60.08%

Skin care and healthcare products

90.56K

24.44%

Health and wellness services

38.93K

10.51%

Energized Mineral Concentrate

15.81K

4.27%

Green energy

1.27K

0.34%

Otro

1.37K

0.37%

La empresa aún no ha revelado los datos relevantes.

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Others – Products for the provision of complementary health therapies

222.64K

60.08%

Skin care and healthcare products

90.56K

24.44%

Health and wellness services

38.93K

10.51%

Energized Mineral Concentrate

15.81K

4.27%

Green energy

1.27K

0.34%

Otro

1.37K

0.37%

Estadísticas de accionistas

Actualizado: lun., 12 de ene

Accionistas

Tipos de accionistas

Accionistas

Proporción

Lesser Panda Ltd

7.36%

Global Fartech Ltd

6.90%

Nexus Investments Group Ltd

6.07%

Oceanic Equity Partner Ltd

6.06%

Blue Horizon Capital Ltd

6.05%

Otro

67.57%

Accionistas

Proporción

Lesser Panda Ltd

7.36%

Global Fartech Ltd

6.90%

Nexus Investments Group Ltd

6.07%

Oceanic Equity Partner Ltd

6.06%

Blue Horizon Capital Ltd

6.05%

Otro

67.57%

Tipos de accionistas

Accionistas

Proporción

Corporation

50.53%

Individual Investor

2.04%

Hedge Fund

0.15%

Venture Capital

0.02%

Otro

47.26%

Participación institucional



Actualizado: lun., 8 de dic

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

12

96.83K

0.35%

--

2025Q3

12

96.83K

0.35%

-72.67K

2025Q2

11

169.49K

0.02%

+164.03K

2025Q1

9

5.47K

0.16%

-73.08K

2024Q4

8

71.66K

0.86%

+46.14K

2024Q3

8

25.52K

0.25%

+18.90K

2024Q2

7

6.62K

0.25%

-3.05K

2024Q1

6

9.68K

0.06%

+7.38K

2023Q4

1

578.00

0.00%

+578.00

2023Q3

2

1.39M

36.92%

--

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Lesser Panda Ltd

3.68M

7.36%

+3.68M

--

Mar 24, 2025

Global Fartech Ltd

3.45M

6.9%

+3.45M

--

Mar 24, 2025

Nexus Investments Group Ltd

3.04M

6.07%

+3.04M

--

Mar 24, 2025

Oceanic Equity Partner Ltd

3.03M

6.06%

+3.03M

--

Mar 24, 2025

Blue Horizon Capital Ltd

3.03M

6.05%

+3.03M

--

Mar 24, 2025

Global Ascend Ventures Ltd

3.02M

6.04%

+3.02M

--

Mar 24, 2025

Vanguard Development Holdings Ltd

3.02M

6.03%

+3.02M

--

Mar 24, 2025

Evergreen Strategic Capital Holding Ltd

3.01M

6.02%

+3.01M

--

Mar 24, 2025

Choong (How Kok)

980.45K

1.96%

+574.00

+0.06%

Jan 08, 2025

Citadel Advisors LLC

65.13K

0.13%

+31.85K

+95.70%

Sep 30, 2025

ETFs relacionados



Nombre

Proporción

Sin datos

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1

Fecha

Fecha ex-dividendo

Tipo

Relación

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1